Corcept Therapeutics | CORT - PE Price to Earnings


Corcept Therapeutics reported $94.18 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
ANI Pharmaceuticals USD 98.67 48.54 Sep/2025
Aurora Cannabis CAD 23.27 0 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Bristol-Myers Squibb USD 8.24 9.03 Sep/2025
Corcept Therapeutics USD 94.18 30.36 Sep/2025
Eli Lilly USD 49.87 12.87 Sep/2025
J&J USD 23.62 0.86 Dec/2025
Knight Therapeutics CAD 91.09 0.73 Sep/2025
Merck USD 8.84 0.26 Sep/2025
Novartis USD 15.74 0.15 Sep/2025
Novartis USD 16.05 2.92 Sep/2025
Pacira USD 29.24 6.15 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Supernus Pharmaceuticals USD 39.11 17.08 Sep/2025
TG Therapeutics USD 13.08 75.69 Sep/2025